FDA
-
Gene Therapy is Fighting Rare Diseases in FDA, NIH Program
The technique aims to treat some diseases by gene replacement.
21m listen -
Fed Health IT Officials Highlight 2022 Priorities
Smarter modernization, data, automation, as well as customer and digital services will see the spotlight in 2022.
10m read -
FDA is Working on a Threat Modeling Playbook
Cyber experts at FDA unpack how it is shaping guidance for threat modeling to secure medical devices and health data.
7m read -
Health Agencies Say Interoperability is Key to Sustainable Infrastructure
FDA, ONC and VA leaders address how they’re improving data flows to bolster IT infrastructures.
7m read -
FDA CIO Leads New Digital Transformation Office
Newly confirmed CIO Vid Desai discusses how his role has evolved following the creation of FDA's Digital Transformation Office.
21m listen -
FDA Approves More Boosters for Some
Both Moderna and Johnson & Johnson COVID-19 vaccines are approved for some vaccinated individuals while the agency reviews more data.
7m read -
The Scientific Computing Advocates Behind FDA's Tech Transformation
A group of IT specialists and scientists are fostering collaboration to enact transformational changes across the agency.
7m read -
CDC Director Sides with FDA on COVID-19 Booster Shots
Dr. Rochelle Walensky discusses CDC’s booster dose decision for some individuals and next steps in the regulatory process.
7m read -
Data is at the Heart of Booster Shot Approvals
FDA’s biologics leader explains progress with COVID-19 vaccines and response to emerging variants.
7m read -
How Products Flow through FDA’s Regulatory System
With novel health solutions, drug manufacturers undergo a strict process to get their products to market.
7m read -
Vid Desai Leads FDA’s New Digital Transformation Office as CIO
The agency is taking on tech modernization with new office and new appointments.
7m read -
Reps. DeGette, Upton Aim to Introduce, Pass Cures 2.0 by End of 2021
The new legislation also builds on White House infrastructure goals to improve health care, drug development and more.
7m read
